Online Decision Support Tool to Help Women with Newly Diagnosed Breast Cancer Make Informed Choices About Contralateral Prophylactic Mastectomy

What this Trial Is About

Researchers are evaluating a decision support tool designed to help women newly diagnosed with early stage breast cancer make informed choices about contralateral prophylactic mastectomy CPM. This tool provides evidence-based information on the risk of developing cancer in the opposite breast and the potential life expectancy benefits of CPM. The study is sponsored by M.D. Anderson Cancer Center and aims to assess how acceptable and helpful this tool is during clinical consultations. Participants use the decision making tool during their consultation with a breast cancer surgeon. They complete questionnaires before and after the consultation to measure their understanding and feelings about CPM. The tool is intended to be used jointly by patients and physicians as part of shared decision making, supporting discussions about surgical options. Throughout the study, researchers will evaluate how well the decision support tool is accepted by patients and whether it improves their knowledge about CPM. They will also measure changes in decisional conflict related to the choice of CPM from baseline up to two years. Participants engage in questionnaires and consults as part of the study, which may last up to two years for outcome assessments.

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer